AKRX News and Press, Akorn Inc. From 05/07/19

-Operational improvements drive sequential growth- -Full year outlook anticipates further sequential growth throughout the year- LAKE FOREST, Ill., May 07, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced its&#...

ADNT , AES , AGN , AKRX , AMAG , ARMK , ARRY , ATH , ATKR , AVNS , BCC , BGCP , BLD , BR , BUD , CJ , CLVS , CNHI , CNK , CRL , CROX , CTLT , CWEN , DEA , DF , DNR , DPLO , DXPE , EGRX , EMR , ENR , EXPD , FI , GSKY , GTE , GTX , HAE , HSIC , ICL , IM...

A jury in a Boston federal court has found INSYS Therapeutics ( INSY -2.1% ) founder John Kapoor and four other executives guilty of racketeering in a bribery and kickback scheme to doctors aimed at driving prescription volume for the painkiller fentanyl. More news on: INSYS Therapeuti...

NEW YORK, NY / ACCESSWIRE / April 22, 2019 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bron...

Regional Health Properties (NYSEMKT: RHE ) +140% . More news on: Regional Health Properties, Inc., The KeyW Holding Corporation, Moleculin Biotech, Inc., Stocks on the move, Read more ...

BOSTON, April 19, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP ( www.blockesq.com ), a securities litigation firm representing investors nationwide, reminds investors of the important deadlines listed below. If you have purchased or otherwise acquired any of the securities listed belo...

LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Loteprednol...

The FDA approves  Akorn's (NASDAQ: AKRX ) generic version of GlaxoSmithKline's (NYSE: GSK ) allergy med Flonase (fluticasone propionate). More news on: Akorn, Inc., GlaxoSmithKline plc, Innovus Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...

LAKE FOREST, Ill., April 18, 2019 (GLOBE NEWSWIRE) -- Akorn, Inc. (Nasdaq: AKRX), a leading specialty generic pharmaceutical company, today announced that it received a new Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for Fluticasone...

Gainers: URI   +7.1% . LVS   +3.1% . RDNT   +2.5% . ETFC   +2.1% . More news on: United Rentals, Inc., Las Vegas Sands Corp., RadNet, Inc., Stocks on the move, Read more ...